Use of injectable progestin contraception and risk of STI among South African women

Contraception

Volumn 80, Issue 6, 2009, Pages 555-560

  Pettifor, Audrey ^a   Delany, Sinead ^b   Kleinschmidt, Immo ^c   Miller, William C ^a   Atashili, Julius ^a   Rees, Helen ^b  

^a IL   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Contraception; Progesterone; Sexually transmitted diseases; South Africa; Women

Indexed keywords

MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE;

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; FOLLOW UP; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS;

ADOLESCENT; ADULT; CONDOMS; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MULTIVARIATE ANALYSIS; NORETHINDRONE; PATIENT SELECTION; PREGNANCY; REGRESSION ANALYSIS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SOUTH AFRICA; VAGINITIS;

EID: 70350774355     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.06.007     Document Type: Article

References (20)

1. South African Department of Health. National HIV antenatal seroprevalence survey 2005 (2006), South African Department of Health, Pretoria
2. Pettifor A., Kleinschmidt I., Levine J., et al. A community based study to examine the effect of a youth HIV prevention intervention on young people age 15-24 in South Africa: results of a baseline survey. Trop Med Int Health 10 (2005) 971-980
3. Baeten J.M., Nyange P.M., Richardson B.A., et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185 (2001) 380-385
4. Morrison C., Bright P., Wong E., et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31 (2004) 561-567
5. Baeten J.M., Lavreys L., and Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 45 (2007) 360-369
6. South African Department of Health. South African Demographic and Health Survey 1998 (2001), South African Department of Health, Pretoria
7. Smit J., Gray A., McFadyen L., and Zuma K. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. BMC Health Serv Res 1 (2001) 4
8. World Health Organization. Medical eligibility criteria for contraceptive use (2004), World Health Organization, Geneva
9. Morrison C.S., Kwok C., Chen P., et al. Hormonal contraception and the acquisition of cervical chlamydial and gonococcal infections. 17th International Society for Sexually Transmitted Diseases Research, Seattle, WA (2007)
10. Kleinschmidt I., Rees H., Delany S., et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 75 (2007) 461-467
11. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 80 (2004) 8-11
12. Morrison C.S., Richardson B.A., Mmiro F., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007) 85-95
13. Bahamondes L., Trevisan M., Andrade L., et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 62 (2000) 23-27
14. Miller L., Patton D.L., Meier A., Thwin S.S., Hooton T.M., and Eschenbach D.A. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 96 (2000) 431-439
15. Taha T.E., Hoover D.R., Dallabetta G.A., et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12 (1998) 1699-1706
16. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 74 (1998) 11-19
17. Ford L.C., Hammill H.A., DeLange R.J., et al. Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones. Am J Obstet Gynecol 156 (1987) 1119-1121
18. Ryu J.S., Choi H.K., Min D.Y., Ha S.E., and Ahn M.H. Effect of iron on the virulence of Trichomonas vaginalis. J Parasitol 87 (2001) 457-460
19. Demes P., Gombosova A., Valent M., Fabusova H., and Janoska A. Fewer Trichomonas vaginalis organisms in vaginas of infected women during menstruation. Genitourin Med 64 (1988) 22-24
20. Eschenbach D.A., Thwin S.S., Patton D.L., et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 30 (2000) 901-907